These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 21866665

  • 1. [Effect of shugan jianpi bushen recipe on splenic T lymphocytes and virus load in hepatitis B virus transgenic mice].
    Liu YM, Guo XB.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):937-40. PubMed ID: 21866665
    [Abstract] [Full Text] [Related]

  • 2. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV.
    Antivir Ther; 2007 Jul; 12(5):705-18. PubMed ID: 17713154
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [Abstract] [Full Text] [Related]

  • 4. [Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
    Li D, Yan YP, Xu DZ, Men K, Zhang JX, Lei XY.
    Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):315-9. PubMed ID: 15938781
    [Abstract] [Full Text] [Related]

  • 5. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
    You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Li YL, Lei H, Liu J, Chen HY, Tang BZ, Huang JH.
    BMC Infect Dis; 2008 Sep 22; 8():123. PubMed ID: 18803883
    [Abstract] [Full Text] [Related]

  • 6. [Correlational analysis of alternation of clinical features of intrahepatic lymphocyte subsets with HBV virology and liver fibrosis in HBV-Tg composite CCl(4) mice model].
    Sun X, Huang K, Zhang M, Liu HL, Zhao ZM, Tao YY, Peng Y, Liu CH.
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul 20; 28(7):580-585. PubMed ID: 32791793
    [Abstract] [Full Text] [Related]

  • 7. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
    Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.
    J Gastroenterol Hepatol; 2010 Aug 20; 25(8):1374-80. PubMed ID: 20659226
    [Abstract] [Full Text] [Related]

  • 8. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH, Ren XN, Chen LX, Shi BS, Xu CH, Fang Z, Liu X, Chen JL, Zhang XN, Hu YW, Zhou XH.
    World J Gastroenterol; 2015 Mar 28; 21(12):3527-36. PubMed ID: 25834317
    [Abstract] [Full Text] [Related]

  • 9. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
    Yang HJ, Lee JH, Kim YJ, Yoon JH, Lee HS.
    J Med Virol; 2012 Mar 28; 84(3):424-30. PubMed ID: 22246827
    [Abstract] [Full Text] [Related]

  • 10. Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B.
    Chu M, Cho SM, Choe BH, Cho MH, Kwon S, Lee WK.
    J Pediatr Gastroenterol Nutr; 2012 Dec 28; 55(6):648-52. PubMed ID: 22688509
    [Abstract] [Full Text] [Related]

  • 11. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
    Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.
    Antiviral Res; 2007 Aug 28; 75(2):146-51. PubMed ID: 17400303
    [Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
    Yoon SK, Seo YB, Im SJ, Bae SH, Song MJ, You CR, Jang JW, Yang SH, Suh YS, Song JS, Kim BM, Kim CY, Jeong SH, Sung YC.
    Liver Int; 2015 Mar 28; 35(3):805-15. PubMed ID: 24620920
    [Abstract] [Full Text] [Related]

  • 13. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
    Ling N, Zhou Z, Zhang DZ, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2007 May 28; 15(5):346-9. PubMed ID: 17524266
    [Abstract] [Full Text] [Related]

  • 14. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
    Arasli M, Ustundag Y, Delikanli B, Harmandar F, Buyukuysal C.
    Hepatogastroenterology; 2012 May 28; 59(115):851-7. PubMed ID: 22193343
    [Abstract] [Full Text] [Related]

  • 15. Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells.
    Li M, Sun XH, Zhou ZH, Yu Z, Jin SG, Zhu XJ, Gao YQ.
    J Ethnopharmacol; 2013 Mar 27; 146(2):614-22. PubMed ID: 23395622
    [Abstract] [Full Text] [Related]

  • 16. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Dusséaux M, Masse-Ranson G, Darche S, Ahodantin J, Li Y, Fiquet O, Beaumont E, Moreau P, Rivière L, Neuveut C, Soussan P, Roingeard P, Kremsdorf D, Di Santo JP, Strick-Marchand H.
    Gastroenterology; 2017 Dec 27; 153(6):1647-1661.e9. PubMed ID: 28851562
    [Abstract] [Full Text] [Related]

  • 17. Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants.
    Carrouée-Durantel S, Durantel D, Werle-Lapostolle B, Pichoud C, Naesens L, Neyts J, Trépo C, Zoulim F.
    Antivir Ther; 2008 Dec 27; 13(3):381-8. PubMed ID: 18572751
    [Abstract] [Full Text] [Related]

  • 18. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
    Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R.
    J Hepatol; 2007 Sep 27; 47(3):366-72. PubMed ID: 17561304
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
    Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.
    Hepatology; 2009 Oct 27; 50(4):1064-71. PubMed ID: 19637288
    [Abstract] [Full Text] [Related]

  • 20. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil.
    Liu Y, Li X, Xin S, Xu Z, Chen R, Yang J, Liu L, Wong VW, Yang D, Chan HL, Xu D.
    J Viral Hepat; 2015 Mar 27; 22(3):328-34. PubMed ID: 25132017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.